Seeyond Eli Lilly & CO Transaction History

Seeyond

$1.03 Billion
Q4 2022

A detailed history of Seeyond transactions in Eli Lilly & CO stock. As of the latest transaction made, Seeyond holds 14,606 shares of LLY stock, worth $11.6 Million. This represents 0.52% of its overall portfolio holdings.

Number of Shares

14,606

Previous 11,601 25.9%

Holding current value

$11.6 Million

Previous $3.75 Million 42.44%

% of portfolio

0.52%

Previous 0.45%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$321.55 - $374.67 $966,257 - $1.13 Million	3,005 Added 25.9%	14,606 $5.34 Million
Q3 2022 Nov 14, 2022	BUY	$296.48 - $337.87 $371,489 - $423,351	1,253 Added 12.11%	11,601 $3.75 Million
Q2 2022 Aug 12, 2022	BUY	$278.73 - $327.27 $53,794 - $63,163	193 Added 1.9%	10,348 $3.36 Million
Q1 2022 May 13, 2022	SELL	$234.69 - $291.66 $4,693 - $5,833	-20 Reduced 0.2%	10,155 $2.91 Million
Q4 2021 Feb 14, 2022	SELL	$224.85 - $279.04 $6,295 - $7,813	-28 Reduced 0.27%	10,175 $2.81 Million
Q3 2021 Nov 12, 2021	SELL	$221.6 - $272.71 $1.3 Million - $1.6 Million	-5,879 Reduced 36.56%	10,203 $2.36 Million
Q2 2021 Aug 13, 2021	SELL	$180.55 - $233.54 $28,165 - $36,432	-156 Reduced 0.96%	16,082 $3.69 Million
Q1 2021 May 14, 2021	SELL	$164.32 - $212.72 $377,936 - $489,256	-2,300 Reduced 12.41%	16,238 $3.03 Million
Q4 2020 Feb 12, 2021	SELL	$130.46 - $172.63 $620,859 - $821,546	-4,759 Reduced 20.43%	18,538 $3.13 Million
Q3 2020 Nov 12, 2020	BUY	$146.22 - $169.13 $561,192 - $649,120	3,838 Added 19.72%	23,297 $3.45 Million
Q2 2020 Aug 13, 2020	SELL	$136.42 - $164.18 $255,105 - $307,016	-1,870 Reduced 8.77%	19,459 $3.2 Million
Q1 2020 May 14, 2020	SELL	$119.05 - $147.35 $38,810 - $48,036	-326 Reduced 1.51%	21,329 $79,000
Q4 2019 Feb 14, 2020	SELL	$106.92 - $132.43 $679,904 - $842,122	-6,359 Reduced 22.7%	21,655 $2.85 Million
Q3 2019 Nov 13, 2019	BUY	$106.79 - $116.16 $83,402 - $90,720	781 Added 2.87%	28,014 $3.13 Million
Q2 2019 Aug 13, 2019	SELL	$110.79 - $129.32 $337,687 - $394,167	-3,048 Reduced 10.07%	27,233 $3.02 Million
Q1 2019 May 15, 2019	BUY	$111.31 - $131.02 $769,931 - $906,265	6,917 Added 29.61%	30,281 $3.93 Million
Q4 2018 Feb 14, 2019	BUY	$105.9 - $118.64 $2.47 Million - $2.77 Million	23,364 New	23,364 $2.7 Million

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Seeyond, based on Form 13F filings with the SEC.

News

Stay updated on Seeyond with notifications on news.

Account